FDA Device Intelligence
HomeBIO-RAD LABORATORIES, INC. › BioPlex 2200

BioPlex 2200

BIO-RAD LABORATORIES, INC. · Model SW4_ V3 · UDI-DI 00847865003186

LFZLKQLFX
10
510(k) clearances
305
Adverse events
9
Recalls
29
Facilities

Description

Rubella & CMV Assay Protocol File CD, SW4_v3

Recalls

DateFirmReason
2025-11-03GET TESTED INTERNATIONAL ABDistribution without premarket approval/clearance.
2022-10-19Bio-Rad Laboratories, Inc.Due to an unusual increase in the positivity rate with human IgM antibodies to cytomegalovirus (CMV) Enzyme Immunoassay (EIA).
2017-01-11BioMerieux SADuring development of the VIDAS 3 software version 1.2, some anomalies have been identified and observed to be already present in the current software version VIDAS 3 version 1.1.4
2015-03-26Diamedix CorporationProduct contained an incorrect substrate.
2009-01-19Abbott LaboratoriesDefective caps: Customers have observed reagent bottles not opening appropriately, which could lead to a probe crash on the instrument.
2007-04-23Abbott LaboratoriesFailure of the AxSYM instrument to open (actuate) some reagent packs from certain lots. The defects can result in probe crashes if not detected prior to placement of the reagent k
2004-06-09bioMerieuxThe product may give false positive results.
2003-06-18Meridian Bioscience IncThe Low Positive Standard kit component is losing potency that may result in false positive test results.
2003-06-12Zeus Scientific IncThe Calibrator included within the kit may be losing reactivity.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.